A Phase II Study of Preradiotherapy Chemotherapy Followed by Hyperfractionated Radiotherapy for Newly Diagnosed High-Risk Medulloblastoma/Primitive Neuroectodermal Tumor: A Report From the Children's Oncology Group (CCG 9931)
Year: 2009
Type: article
Study design: Clinical Trial
Institutions: NYU Langone Health, New York University, Maimonides Medical Center, Children's Hospital of Philadelphia, Children's Hospital of Pittsburgh, C. S. Mott Children's Hospital, University of Southern California, Children's Hospital Los Angeles, Children's Oncology Group, Children's National, University of Michigan, University of Wisconsin–Madison, University of Wisconsin American Family Children's Hospital, University of California, San Francisco, University of California San Francisco Medical Center, Methodist Children’s Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: G7558764758, G997771125
OpenAlex ID: W2051027428
